205 related articles for article (PubMed ID: 20587594)
1. Btk-dependent Rac activation and actin rearrangement following FcepsilonRI aggregation promotes enhanced chemotactic responses of mast cells.
Kuehn HS; Rådinger M; Brown JM; Ali K; Vanhaesebroeck B; Beaven MA; Metcalfe DD; Gilfillan AM
J Cell Sci; 2010 Aug; 123(Pt 15):2576-85. PubMed ID: 20587594
[TBL] [Abstract][Full Text] [Related]
2. Btk plays a crucial role in the amplification of Fc epsilonRI-mediated mast cell activation by kit.
Iwaki S; Tkaczyk C; Satterthwaite AB; Halcomb K; Beaven MA; Metcalfe DD; Gilfillan AM
J Biol Chem; 2005 Dec; 280(48):40261-70. PubMed ID: 16176929
[TBL] [Abstract][Full Text] [Related]
3. Differential use of BTK and PLC in FcεRI- and KIT-mediated mast cell activation: A marginal role of BTK upon KIT activation.
Simonowski A; Wilhelm T; Habib P; Zorn CN; Huber M
Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118622. PubMed ID: 31837347
[TBL] [Abstract][Full Text] [Related]
4. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation.
Kawakami Y; Kitaura J; Satterthwaite AB; Kato RM; Asai K; Hartman SE; Maeda-Yamamoto M; Lowell CA; Rawlings DJ; Witte ON; Kawakami T
J Immunol; 2000 Aug; 165(3):1210-9. PubMed ID: 10903718
[TBL] [Abstract][Full Text] [Related]
5. Absence of Tec family kinases interleukin-2 inducible T cell kinase (Itk) and Bruton's tyrosine kinase (Btk) severely impairs Fc epsilonRI-dependent mast cell responses.
Iyer AS; Morales JL; Huang W; Ojo F; Ning G; Wills E; Baines JD; August A
J Biol Chem; 2011 Mar; 286(11):9503-13. PubMed ID: 21212279
[TBL] [Abstract][Full Text] [Related]
6. The phosphoinositide 3-kinase-dependent activation of Btk is required for optimal eicosanoid production and generation of reactive oxygen species in antigen-stimulated mast cells.
Kuehn HS; Swindle EJ; Kim MS; Beaven MA; Metcalfe DD; Gilfillan AM
J Immunol; 2008 Dec; 181(11):7706-12. PubMed ID: 19017959
[TBL] [Abstract][Full Text] [Related]
7. Prevention of F-actin assembly switches the response to SCF from chemotaxis to degranulation in human mast cells.
Smrž D; Bandara G; Beaven MA; Metcalfe DD; Gilfillan AM
Eur J Immunol; 2013 Jul; 43(7):1873-82. PubMed ID: 23616175
[TBL] [Abstract][Full Text] [Related]
8. TRPM4 regulates migration of mast cells in mice.
Shimizu T; Owsianik G; Freichel M; Flockerzi V; Nilius B; Vennekens R
Cell Calcium; 2009 Mar; 45(3):226-32. PubMed ID: 19046767
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production.
Hata D; Kawakami Y; Inagaki N; Lantz CS; Kitamura T; Khan WN; Maeda-Yamamoto M; Miura T; Han W; Hartman SE; Yao L; Nagai H; Goldfeld AE; Alt FW; Galli SJ; Witte ON; Kawakami T
J Exp Med; 1998 Apr; 187(8):1235-47. PubMed ID: 9547335
[TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 activates and utilizes mTORC2 as a central signaling locus for the regulation of mast cell chemotaxis and mediator release.
Kuehn HS; Jung MY; Beaven MA; Metcalfe DD; Gilfillan AM
J Biol Chem; 2011 Jan; 286(1):391-402. PubMed ID: 20980255
[TBL] [Abstract][Full Text] [Related]
12. Defective degranulation and calcium mobilization of bone-marrow derived mast cells from Xid and Btk-deficient mice.
Setoguchi R; Kinashi T; Sagara H; Hirosawa K; Takatsu K
Immunol Lett; 1998 Dec; 64(2-3):109-18. PubMed ID: 9870661
[TBL] [Abstract][Full Text] [Related]
13. Synergistic activation of phospholipases Cgamma and Cbeta: a novel mechanism for PI3K-independent enhancement of FcepsilonRI-induced mast cell mediator release.
Kuehn HS; Beaven MA; Ma HT; Kim MS; Metcalfe DD; Gilfillan AM
Cell Signal; 2008 Apr; 20(4):625-36. PubMed ID: 18207701
[TBL] [Abstract][Full Text] [Related]
14. Stimulus strength determines the BTK-dependence of the SHIP1-deficient phenotype in IgE/antigen-triggered mast cells.
Zorn CN; Simonowski A; Huber M
Sci Rep; 2018 Oct; 8(1):15467. PubMed ID: 30341350
[TBL] [Abstract][Full Text] [Related]
15. Stem cell factor has a suppressive activity to IgE-mediated chemotaxis of mast cells.
Sawada J; Shimizu S; Tamatani T; Kanegasaki S; Saito H; Tanaka A; Kambe N; Nakahata T; Matsuda H
J Immunol; 2005 Mar; 174(6):3626-32. PubMed ID: 15749900
[TBL] [Abstract][Full Text] [Related]
16. Impaired signaling via the high-affinity IgE receptor in Wiskott-Aldrich syndrome protein-deficient mast cells.
Pivniouk VI; Snapper SB; Kettner A; Alenius H; Laouini D; Falet H; Hartwig J; Alt FW; Geha RS
Int Immunol; 2003 Dec; 15(12):1431-40. PubMed ID: 14645152
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase-deficient Wv c-kit induces mast cell adhesion and chemotaxis.
Dastych J; Taub D; Hardison MC; Metcalfe DD
Am J Physiol; 1998 Nov; 275(5):C1291-9. PubMed ID: 9814978
[TBL] [Abstract][Full Text] [Related]
18. SHP2 phosphatase promotes mast cell chemotaxis toward stem cell factor via enhancing activation of the Lyn/Vav/Rac signaling axis.
Sharma N; Everingham S; Ramdas B; Kapur R; Craig AW
J Immunol; 2014 May; 192(10):4859-66. PubMed ID: 24733849
[TBL] [Abstract][Full Text] [Related]
19. Cytoskeletal Protein 4.1R Is a Positive Regulator of the FcεRI Signaling and Chemotaxis in Mast Cells.
Draberova L; Draberova H; Potuckova L; Halova I; Bambouskova M; Mohandas N; Draber P
Front Immunol; 2019; 10():3068. PubMed ID: 31993060
[TBL] [Abstract][Full Text] [Related]
20. A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses.
Smrž D; Bandara G; Zhang S; Mock BA; Beaven MA; Metcalfe DD; Gilfillan AM
J Immunol Methods; 2013 Apr; 390(1-2):52-62. PubMed ID: 23357051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
